Preliminary Program
Stream 7: Frontiers of Cancer Diagnostics/Therapeutics
|
Forum 7-1: Immunogenomic IT and Precision Oncology |
|
|
Day 2: Morning, May 12, 2022 |
|
|
Chair |
Call for Chair |
|
Co-chair |
Call for Co-chair |
|
Time |
Speeches and Speakers |
|
08:30-08:35 |
Chair’s Introduction |
|
08:35-09:00 |
Speech Opportunity Available |
|
09:00-09:25 |
Speech Opportunity Available |
|
09:25-09:50 |
Speech Opportunity Available |
|
09:50-10:15 |
Speech Opportunity Available |
|
10:15-10:30 |
Coffee Break |
|
10:30-10:55 |
Speech Opportunity Available |
|
10:55-11:20 |
Speech Opportunity Available |
|
11:20-11:45 |
Speech Opportunity Available |
|
11:45-12:10 |
Speech Opportunity Available |
|
Forum 7-2: Liquid Biopsy |
|
|
Day 2: Morning, May 12, 2022 |
|
|
Chair |
Dr. Yan Wang, Chief Executive Officer & Chairman, QuestGenomics, China |
|
Co-chair |
Call for Co-chair |
|
Time |
Speeches and Speakers |
|
08:30-08:35 |
Chair’s Introduction |
|
08:35-09:00 |
Title: TBD Dr. Yves Rozenholc, Head of Research Unit UR7537 - BioSTM, Université de Paris, France
|
|
09:00-09:25 |
Title: Real Time Digital PCR Improves the Sensitivity for Liquid Biopsy Dr. Yan Wang, Chief Executive Officer & Chairman, QuestGenomics, China
|
|
09:25-09:50 |
Speech Opportunity Available |
|
09:50-10:15 |
Speech Opportunity Available |
|
10:15-10:30 |
Coffee Break |
|
10:30-10:55 |
Speech Opportunity Available |
|
10:55-11:20 |
Speech Opportunity Available |
|
11:20-11:45 |
Speech Opportunity Available |
|
11:45-12:10 |
Speech Opportunity Available |
|
Forum 7-3: Cancer Imaging |
|
|
Day 2: Afternoon, May 12, 2022 |
|
|
Chair |
Call for Chair |
|
Co-chair |
Call for Co-chair |
|
Time |
Speeches and Speakers |
|
13:30-13:35 |
Chair’s Introduction |
|
13:35-14:05 |
Speech Opportunity Available |
|
14:05-14:30 |
Dr. Daxiang Cui, Distinguished Professor, Shanghai Jiao Tong University, China |
|
14:30-14:55 |
Speech Opportunity Available |
|
14:55-15:20 |
Speech Opportunity Available |
|
15:20-15:35 |
Coffee Break |
|
15:35-16:00 |
Speech Opportunity Available |
|
16:00-16:25 |
Speech Opportunity Available |
|
16:25-16:50 |
Speech Opportunity Available |
|
16:50-17:15 |
Speech Opportunity Available |
|
Forum 7-5: DNA Damage Response (DDR) Treatment |
|
|
Day 2: Afternoon, May 12, 2022 |
|
|
Chair |
Call for Chair |
|
Co-chair |
Call for Co-chair |
|
Time |
Speeches and Speakers |
|
13:30-13:35 |
Chair’s Introduction |
|
13:35-14:05 |
Speech Opportunity Available |
|
14:05-14:30 |
Speech Opportunity Available |
|
14:30-14:55 |
Speech Opportunity Available |
|
14:55-15:20 |
Speech Opportunity Available |
|
15:20-15:35 |
Coffee Break |
|
15:35-16:00 |
Speech Opportunity Available |
|
16:00-16:25 |
Speech Opportunity Available |
|
16:25-16:50 |
Speech Opportunity Available |
|
16:50-17:15 |
Speech Opportunity Available |
|
Forum 7-6: Noninvasive Real-Time Cancer Monitoring |
|
|
Day 3: Morning, May 13, 2022 |
|
|
Chair |
Call for Chair |
|
Co-chair |
Call for Co-chair |
|
Time |
Speeches and Speakers |
|
08:30-08:35 |
Chair’s Introduction |
|
08:35-09:00 |
Speech Opportunity Available |
|
09:00-09:25 |
Speech Opportunity Available |
|
09:25-09:50 |
Speech Opportunity Available |
|
09:50-10:15 |
Speech Opportunity Available |
|
10:15-10:30 |
Coffee Break |
|
10:30-10:55 |
Speech Opportunity Available |
|
10:55-11:20 |
Speech Opportunity Available |
|
11:20-11:45 |
Speech Opportunity Available |
|
11:45-12:10 |
Speech Opportunity Available |
|
Forum 7-7: Cancer Targeted Drug Delivery |
|
|
Day 3: Afternoon, May 13, 2022 |
|
|
Chair |
Call for Chair |
|
Co-chair |
Call for Co-chair |
|
Time |
Speeches and Speakers |
|
13:30-13:35 |
Chair’s Introduction |
|
13:35-14:05 |
Speech Opportunity Available |
|
14:05-14:30 |
Speech Opportunity Available |
|
14:30-14:55 |
Speech Opportunity Available |
|
14:55-15:20 |
Speech Opportunity Available |
|
15:20-15:35 |
Coffee Break |
|
15:35-16:00 |
Speech Opportunity Available |
|
16:00-16:25 |
Speech Opportunity Available |
|
16:25-16:50 |
Speech Opportunity Available |
|
16:50-17:15 |
Speech Opportunity Available |
Contact Us: Email:Mandy@bitcongress.com
Company Name: 3F, Building 2, Dalian Life Science Innovation Center, 43 Huoju Road,
Hi-tech Industrial Zone, Dalian City, Liaoning Province, China
Copyright © 2008-2022 BIT Congress